oppalerts.com →
IVF Reproductive Medicine

First IVF Planner

Knowledge Graph Entities
Dominant · Reddit Comments ρ=0.382

AI recommendation signal analysis across 238 domains for the First IVF Planner persona in IVF Reproductive Medicine.

238Domains Tracked
First IVF Planner_persona.report
EntityScore
Texas Fertility Center
62.7
Prelude Fertility
62.7
Pacific Fertility Center Los Angeles (PFCLA)
62.7
Facial plastic surgery & aesthetic medicine
60.0
Colorado Center for Reproductive Medicine
53.9
Want a custom AI visibility audit for IVF Reproductive Medicine?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch
About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches First IVF Planner. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

19K
Entities With Topic Matches
1,894
Entities Mentioning Brands
20K
Topic Phrase Matches
2,077
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

7 of 25 top domains for First IVF Planner have a knowledge-graph entity.

DomainKnowledge Graph EntityWikidata ID
fertilityiq.comNot in the knowledge graph-
resolve.orgNot in the knowledge graph-
sart.orgNot in the knowledge graph-
asrm.orgAmerican Society for Reproductive MedicineQ466817
cdc.govCDC's COVID-19 Travel Recommendations by CountryQ91317897
shadygrovefertility.comShady Grove Fertility CenterQ30281964
resolve.comNot in the knowledge graph-
ccrmivf.comColorado Center for Reproductive MedicineQ30281877
reproductivefacts.orgNot in the knowledge graph-
rmanetwork.comNot in the knowledge graph-
cnyfertility.comNot in the knowledge graph-
kindbody.comNot in the knowledge graph-
springfertility.comNot in the knowledge graph-
progyny.comProgyny, Inc.Q125862778
fertilityoutreach.comNot in the knowledge graph-
sartfertility.orgNot in the knowledge graph-
rmany.comReproductive Medicine Associates of New YorkQ30274383
generationnextfertility.comNot in the knowledge graph-
fertilityanswers.comNot in the knowledge graph-
advancedfertility.comNot in the knowledge graph-
rescripted.comNot in the knowledge graph-
fertilityoutloud.comNot in the knowledge graph-
babycenter.comBabyCenterQ4838174
sartcorsonline.comNot in the knowledge graph-
fertilityclinicreviews.comNot in the knowledge graph-
Wikidata

Top knowledge-graph entities

The entity records where First IVF Planner's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.


EntityBlendedBrand MentionsTopic Matches
Texas Fertility Center62.731
Prelude Fertility62.731
Pacific Fertility Center Los Angeles (PFCLA)62.731
Facial plastic surgery & aesthetic medicine60.060
Colorado Center for Reproductive Medicine53.921
Sher Fertility53.921
Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation53.921
Mayo Clinic49.640
Cleveland Clinic49.640
Trends in Amplification49.640
National Institute for Occupational Safety and Health42.730
Q22988342.730
United States National Institutes of Health42.730
JAMA Facial Plastic Surgery42.730
Psychological Reports42.730
Applied Biosafety42.730
Vital and health statistics. Series 21, Data on natality, marriage, and divorce42.730
Vital and health statistics. Series 5, Comparative international vital and health statistics reports42.730
Industrial biotechnology (New Rochelle, N.Y.)42.730
Pacific Fertility Center42.730
Office of Readiness and Response42.730
Challenges and strategies in building a foundational digital health data integration ecosystem: a systematic review and thematic synthesis42.730
Clinical trial NCT0759738242.730
Clinical trial NCT0758582542.730
Clinical trial NCT0757161642.730
Clinical trial NCT0757162942.730
Clinical trial NCT0761103242.730
American Society for Reproductive Medicine41.411
Reproductive Medicine Associates of New York41.411
Reproductive Medicine Associates of New Jersey41.411
assisted reproductive technology40.003
fertility clinic40.003
Fertility and Sterility40.003
Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination40.003
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?40.003
Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility.40.003
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials40.003
Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable?40.003
There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy40.003
Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET40.003
Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics40.003
Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment40.003
Androgenicity and fertility treatment in women with unexplained infertility40.003
Evaluating the benefit of measuring serum progesterone prior to the administration of HCG: effect of the duration of late-follicular elevated progesterone following ovarian stimulation on fresh embryo transfer live birth rates40.003
Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility40.003
Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes40.003
Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database40.003
GYN-FIV a.s.40.003
Nucleic Acids Research33.920
Newsweek33.920
Administration Science Quarterly33.920
Ferring Pharmaceuticals33.920
March of Dimes33.920
Bulletin of the Atomic Scientists33.920
Epi Info33.920
American Journal of Medical Quality33.920
American Journal of Men's Health33.920
American Journal of Orthodontics and Dentofacial Orthopedics33.920
American Journal of Translational Research33.920
Biomedical Optics Express33.920
ClinicalTrials.gov33.920
dbSNP33.920
Ergonomics in Design33.920
Eunice Kennedy Shriver National Institute of Child Health and Human Development33.920
Geriatric orthopaedic surgery & rehabilitation33.920
HSS Journal33.920
Indian Journal of Psychological Medicine33.920
Journal of Biomolecular Screening33.920
Journal of Fire Sciences33.920
Journal of Positive Behavior Interventions33.920
Journal of Psychoeducational Assessment33.920
Journal of Research in Music Education33.920
LabCorp33.920
Preventing Chronic Disease33.920
Proceedings of the Human Factors and Ergonomics Society Annual Meeting33.920
Western Journal of Medicine33.920
Simulation & Gaming33.920
Topics in Early Childhood Special Education33.920
UPDATE: Applications of Research in Music Education33.920
Ulster Medical Journal33.920
Violence Against Women33.920
The AAPS Journal33.920
Rice33.920
Journal of Correctional Health Care33.920
Gastrointestinal Endoscopy33.920
New Labor Forum33.920
Antitrust Bulletin33.920
AAPS PharmSciTech33.920
International Journal of Mental Health Systems33.920
Technology in Cancer Research and Treatment33.920
Learning Disability Quarterly33.920
American String Teacher33.920
Journal of Urban Health33.920
Cell Transplantation33.920
Neural Development33.920
Journal of International Marketing33.920
North American Archaeologist33.920
International Journal of Qualitative Methods33.920
The Review of Black Political Economy33.920
Journal of the Society of Laparoendoscopic Surgeons33.920
International Journal of Educational Reform33.920
Environmental Health Insights33.920
Natural Product Communications33.920
HealthGrades33.920
National Survey of Family Growth33.920
National Vital Statistics System33.920
NIOSH Power Tools Database33.920
Q2064174233.920
Oregon Graduate Center33.920
Morbidity and Mortality Weekly Report: Recommendations and Reports33.920
Childhood Obesity33.920
Hispanic health care international : the official journal of the National Association of Hispanic Nurses33.920
The Journal of clinical and aesthetic dermatology33.920
Annals of Neurosciences33.920
Alcohol research : current reviews33.920
Vital & health statistics. Series 3, Analytical and epidemiological studies33.920
Pulmonary circulation33.920
Dermato-endocrinology33.920
British Heart Journal33.920
United European gastroenterology journal33.920
The western journal of emergency medicine33.920
Craniomaxillofacial trauma & reconstruction33.920
Psychiatry33.920
Advances in Wound Care33.920
Mycobiology33.920
Vital and health statistics. Series 3, Analytical studies33.920
Vital and health statistics. Ser. 4, Documents and committee reports33.920
Vital and health statistics. Series 13, Data from the National Health Survey33.920
Aging trends (Hyattsville, Md.)33.920
Simulation & games33.920
NCHS data brief33.920
Magnetic resonance insights33.920
Biomedical informatics insights33.920
Clinical Medicine Insights. Cardiology33.920
Clinical medicine insights. Case reports33.920
Clinical medicine insights. Pathology33.920
Nutrition and metabolic insights33.920
Allergy & rhinology (Providence, R.I.)33.920
i-Perception33.920
Journal of Central Nervous System Disease33.920
Plastic surgery (Oakville, Ont.)33.920
MMWR supplements33.920
Transgender Health33.920
National Center for Emerging and Zoonotic Infectious Diseases33.920
Division of Parasitic Diseases and Malaria33.920
San Diego Fertility Center33.920
Chronic Disease Prevention and Health Promotion33.920
Fertility Center of Las Vegas33.920
Shady Grove Fertility Center33.920
CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows33.920
Johns Hopkins Medicine33.920
Journal of Patient Experience33.920
OTO Open33.920
Advances in Methods and Practices in Psychological Science33.920
Abstracts in Anthropology33.920
Journal of Chinese Writing Systems33.920
bidirectional encoder representations from transformers33.920
Health Equity33.920
Christopher R. Conley33.920
Journal of patient safety and risk management33.920
Journal of Advertising Education33.920
International Journal of Cosmetic Surgery and Aesthetic Dermatology33.920
Q9660291433.920
Cultures of Science33.920
Handbook of Practice Management33.920
Plastic Surgery Case Studies33.920
University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism33.920
data.cdc.gov33.920
Equity in education & society33.920
Healthcare Infection Control Practices Advisory Committee33.920
SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph33.920
Progyny, Inc.33.920
Clinical Pathology33.920
WebMD Magazine33.920
GoodLeap31.702
Journal of Assisted Reproduction and Genetics31.702
Reproductive Medicine and Biology31.702
Naprotechnology31.702
Post-embryo transfer interventions for assisted reproduction technology cycles31.702
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles31.702
Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility31.702
The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment31.702
In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities31.702
Q2834460531.702
Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic31.702
Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.31.702
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility31.702
Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics31.702
Predictors of participant retention in infertility treatment trials31.702
Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique31.702
Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates31.702
Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues31.702
Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction.31.702
Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles31.702
A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T)31.702
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.31.702
How the FMR1 gene became relevant to female fertility and reproductive medicine31.702
Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer31.702
Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature31.702
Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes31.702
Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort31.702
Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation31.702
Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction31.702
Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion31.702
Fertility treatment when the prognosis is very poor or futile31.702
Access to fertility treatment by gays, lesbians, and unmarried persons31.702
Ovarian stimulation in patients with breast cancer31.702
Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience31.702
Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report31.702
Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze31.702
Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study31.702
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility31.702
Optimal timing for elective egg freezing31.702
Predictive value of sperm motility characteristics assessed by computer-assisted sperm analysis in intrauterine insemination with superovulation in couples with unexplained infertility31.702
Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe?31.702
What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality31.702
Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer31.702
Effectiveness and treatment for unexplained infertility31.702
Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles31.702
The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal?31.702
Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation31.702
Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility31.702
Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort31.702
The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer31.702
Sperm chromatin structure assay results in Nigerian men with unexplained infertility31.702
Outcomes of ovarian stimulation after treatment with chemotherapy31.702
Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis31.702
Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction31.702
Mature oocyte retrieval during laparotomic debulking surgery following random-start controlled ovarian stimulation for fertility preservation in a patient with suspected ovarian cancer31.702
A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey31.702
Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons31.702
Oncofertility: a grand collaboration between reproductive medicine and oncology31.702
Guidelines for reducing the risk of viral transmission during fertility treatment31.702
A reassessment of comparative pregnancy and implantation rates following embryo transfer in recipients vs their infertile donors also trying to conceive in the background of performing salpingectomy for hydrosalpinx.31.702
Computer-assisted semen analysis systems: comparison with routine evaluation and prognostic value in male fertility and assisted reproduction31.702
Reluctance of medical professionals in adopting natural-cycle and minimal ovarian stimulation protocols in human clinical assisted reproduction31.702
Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report31.702
Use of letrozole in assisted reproduction: a systematic review and meta-analysis.31.702
Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial31.702
Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction31.702
Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles31.702
Assisted reproduction and fertility preservation techniques in cancer patients31.702
Optimizing natural fertility31.702
Blastocyst culture and transfer in clinical-assisted reproduction31.702
Endometrial signaling pathways during ovarian stimulation for assisted reproduction technology31.702
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients31.702
Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms31.702
Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review31.702
Human immunodeficiency virus and infertility treatment31.702
Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery31.702
Fertility preservation and infertility treatment in breast cancer patients31.702
The promise of in vitro maturation in assisted reproduction and fertility preservation.31.702
Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction31.702
Elective single-embryo transfer31.702
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature31.702
Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer31.702
Ovarian stem cells—Potential roles in infertility treatment and fertility preservation31.702
Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion31.702
The wobbly evidence base of reproductive medicine31.702
Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics31.702
Misconduct in third-party assisted reproduction: a committee opinion31.702
Methods employed to overcome difficult embryo transfer during assisted reproduction treatment31.702
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone31.702
Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders31.702
An Integrated Approach to Male-Factor Subfertility: Bridging the Gap Between Fertility Specialists Trained in Urology and Gynaecology31.702
Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients31.702
Subclinical hypothyroidism in the infertile female population: a guideline31.702
Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer31.702
Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy31.702
The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis31.702
Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility31.702
Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response31.702
Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices31.702
Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers31.702
Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey31.702
Performing the embryo transfer: a guideline31.702
Effect of smoking on ovarian reserve and ovarian stimulation in in- vitro fertilization and embryo transfer31.702
Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion31.702
The case for aromatase inhibitors use in Oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in Breast Cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate31.702
Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study31.702
Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation31.702
Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET).31.702
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.31.702
Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report31.702
Endometrial thickness significantly affects clinical pregnancy and live birth rates in frozen-thawed embryo transfer cycles31.702
Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study31.702
Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: frequency and coping strategies31.702
Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer31.702
Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction?31.702
Fertility preservation and reproduction in cancer patients31.702
Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patients.31.702
Chromatin fluorescence characteristics and standard semen analysis parameters: correlations observed in andrology testing among 136 males referred for infertility evaluation31.702
Cycle-to-cycle variation in utero-ovarian hemodynamic indices in ovarian stimulation and natural cycles of the same women and its effect on the outcome of assisted reproduction treatment.31.702
Luteinizing hormone-releasing hormone agonists for ovarian stimulation in assisted reproduction31.702
Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction31.702
Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.31.702
Ovarian stimulation for assisted reproduction31.702
Mole modifications following controlled ovarian stimulation for assisted reproduction technologies31.702
Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles31.702
Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 201231.702
Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion31.702
Ovarian stimulation in assisted reproduction.31.702
Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle.31.702
Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer31.702
Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure31.702
Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows31.702
Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer31.702
Preprogrammed, unmonitored ovarian stimulation reduces expense without compromising the outcome of assisted reproduction31.702
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression31.702
Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation31.702
IVF Treatment and Single Embryo Transfer31.702
Effect of high-dose estrogen in luteal phase support on live birth rates after assisted reproduction treatment cycles31.702
Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer31.702
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count31.702
Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.31.702
Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients31.702
First live birth following IVF-embryo transfer and use of GnRHa alone for ovarian stimulation31.702
Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction31.702
An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial31.702
Comparison of aneuploidy, pregnancy and live birth rates between day 5 and day 6 blastocysts31.702
Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit31.702
Optimizing natural fertility: a committee opinion31.702
Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong.31.702
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.31.702
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion31.702
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation31.702
Role of semen analysis in subfertile couples31.702
The relationship between endogenous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transfer31.702
The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles31.702
Semen analysis in adolescent cancer patients prior to bone marrow transplantation: when is it too late for fertility preservation?31.702
Follicular fluid-induced acrosome reaction distinguishes a subgroup of men with unexplained infertility not identified by semen analysis31.702
Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen31.702
Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program31.702
The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment31.702
Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility31.702
LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.31.702
Effect of ovarian stimulation on plasma lipid and apolipoprotein concentrations in a population of infertile women undergoing IVF/embryo transfer31.702
IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis31.702
Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.31.702
Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study31.702
Comparison of clinical outcome of mild-stimulation and conventional ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET)31.702
Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation31.702
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility31.702
Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine31.702
Risk-sharing or refund programs in assisted reproduction: a committee opinion31.702
Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.31.702
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial31.702
Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.31.702
Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment31.702
First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient31.702
Comparison of the semen analysis results obtained from two branded computer-aided sperm analysis systems31.702
Human immunodeficiency virus and infertility treatment31.702
Human immunodeficiency virus and infertility treatment31.702
Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation31.702
A Study of Controlled Ovarian Stimulation with Clomiphene Citrate or Letrozole in Combination with Gonadotropins and IUI in Unexplained Infertility31.702
Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'.31.702
Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer31.702
Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin31.702
Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya31.702
Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer31.702
Ovarian stimulation for fertility preservation in patients with cancer31.702
Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation31.702
The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.31.702
Effective method for emergency fertility preservation: random-start controlled ovarian stimulation31.702
Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial31.702
Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation31.702
Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey31.702
Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners31.702
Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study31.702
Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria.31.702
Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy31.702
Factors associated with dizygotic twinning after IVF treatment with double embryo transfer31.702
The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination31.702
Fertility preservation with ovarian stimulation protocols prior to cancer treatment31.702
An analysis of the impact of embryo transfer difficulty on live birth rates, using a standardised grading system31.702
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion31.702
Medical egg freezing: the importance of a patient-centered approach to fertility preservation31.702
Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death31.702
Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial31.702
Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women31.702
Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy31.702
Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients31.702
Cumulative pregnancy and live birth rates through assisted reproduction in women 44-45 years of age: is there any hope?31.702
Does ovarian stimulation regimen affect IVF outcome? a two-centre, real-world retrospective study using predominantly cleavage-stage, single embryo transfer31.702
The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer31.702
Evaluation of trend in semen analysis for 11 years in subjects attending a fertility clinic in India.31.702
Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion31.702
Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion31.702
The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience.31.702
Successful controlled ovarian stimulation despite elevated hCG levels after first-trimester abortion in the context of fertility preservation31.702
Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients31.702
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.31.702
Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India31.702
Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes31.702
The use of luteal-phase ovarian stimulation for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment31.702
Elevated serum estradiol levels in artificial autologous frozen embryo transfer cycles negatively impact ongoing pregnancy and live birth rates31.702
Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer31.702
A specific controlled ovarian stimulation (COS) protocol for fertility preservation in women with breast cancer undergoing neoadjuvant chemotherapy31.702
Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?31.702
Do endometriomas grow during ovarian stimulation for assisted reproduction? A three-dimensional volume analysis before and after ovarian stimulation31.702
The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF.31.702
Self-operated endovaginal telemonitoring versus traditional monitoring of ovarian stimulation in assisted reproduction: an RCT31.702
Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.31.702
The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology31.702
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles31.702
Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer programme after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormone31.702
Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation31.702
Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure31.702
The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women.31.702
Double embryo transfer gives good pregnancy and live birth rates in poor responders with a modest increase in multiple birth rates: results from an observational study31.702
Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined.31.702
Intermittent vaginal injections of gonadotrophins for ovarian stimulation in IVF treatment31.702
Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF.31.702
New alternative to infertility treatment for women without ovarian stimulation.31.702
Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation31.702
Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births31.702
Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study31.702
Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group31.702
Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study31.702
Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles31.702
Endocrinology: Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing in-vitro fertilization and embryo transfer with ovarian stimulation31.702
Selection of ovarian stimulation protocol is related to IVF treatment outcome in women 35 years of age and older31.702
Outcome of donor versus husband insemination in couples with unexplained infertility treated by in vitro fertilization and embryo transfer31.702
Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme31.702
Growth hormone, oestradiol, progesterone and testosterone concentrations in follicular fluid after ovarian stimulation with various regimes for assisted reproduction31.702
Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer31.702
Successful Ovarian Stimulation for Fertility Preservation in a Patient with Chronic Myeloid Leukemia: Switch from Nilotinib to Interferon-α.31.702
Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism31.702
Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction?31.702
On the Origins of the Semen Analysis: A Close Relationship with the History of the Reproductive Medicine31.702
Role of FSHR rs6165 and ESR2 rs4986938 polymorphisms in ovarian stimulation of Iranian women who underwent assisted reproduction treatment31.702
Do trained reproductive endocrinologists perform better than their trainees? Comparing clinical pregnancy rates and live birth rates after transfer of single fresh blastocysts.31.702
Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients31.702
CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer31.702
Bioethical dilemmas of assisted reproduction in the opinions of Polish women in infertility treatment: a research report31.702
Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study31.702
Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers31.702
Semen quality of consecutive ejaculates from cancer patients for fertility preservation31.702
Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome31.702
Use of fetal oocytes in assisted reproduction31.702
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction31.702
Cetrotide confirmatory trial of cetrorelix/0.25 mg in 26 women undergoing ovarian stimulation with recombinant follicle stimulating hormones for IVF, ICSI and embryo transfer (ET).31.702
Changes induced in serum protein profiles by ovarian stimulation during in-vitro fertilization--embryo transfer treatment: a comparison between conception and non-conception cycles31.702
Further observations on serial serum immunoreactive inhibin levels in the luteal phase and early gestation after ovarian stimulation for in vitro fertilization and embryo transfer31.702
Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme31.702
Treatment of patients with unexplained infertility: gamete intrafallopian transfer (GIFT) versus tubal embryo transfer (TET)31.702
Practice patterns among reproductive endocrinologists: further aspects of the infertility evaluation.31.702
Optimizing natural fertility: a committee opinion31.702
Practice patterns among reproductive endocrinologists: the infertility evaluation31.702
Expectations for success in fertility treatment involving assisted reproduction31.702
Reproductive medicine in transition: new developments in embryo transfer31.702
Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs.31.702
Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure31.702
Predictors of psychological distress in patients starting IVF treatment: infertility-specific versus general psychological characteristics31.702
Is there a need for recombinant human luteinizing hormone (lutropin alfa) supplementation in ovarian stimulation for assisted reproduction?31.702
Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An ana31.702
AIDA for reproductive medicine and the fertility clinic31.702
Subnormal sperm parameters in conventional semen analysis are associated with discrepancies between fertilization and pregnancy rates in in-vitro fertilization and embryo transfer31.702
Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation31.702
Pregnancy outcomes of PCOS overweight/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer31.702
Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?31.702
AIUM practice guideline for ultrasonography in reproductive medicine31.702
'Elective single embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances': AGAINST: SET maintains live birth rates and provides unique advantages31.702
Suitable fresh embryo transfer strategy for mild ovarian stimulation with clomiphene citrate31.702
Endometrial Scratch Injury Induces Higher Pregnancy Rate for Women With Unexplained Infertility Undergoing IUI With Ovarian Stimulation: A Randomized Controlled Trial31.702
Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'.31.702
Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women31.702
Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls31.702
Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion31.702
Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation31.702
In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel31.702
The expected cumulative incidence of live birth of patients starting IVF treatment at age 41 years or older31.702
Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer31.702
Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence?31.702
Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference31.702
Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer31.702
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?31.702
Misconduct in third-party assisted reproduction: an Ethics Committee opinion31.702
Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation31.702
Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer31.702
Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion31.702
Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee31.702
Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine31.702
Is tissue factor pathway inhibitor a marker of procoagulable status in healthy infertile women undergoing ovarian stimulation for assisted reproduction?31.702
The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa31.702
Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates31.702
Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction31.702
Unexplained Infertility and the Possibilities of Management with In Vitro Fertilization and Embyro Transfer31.702
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis31.702
Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents31.702
Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved31.702
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer31.702
Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle31.702
Single Human Embryo Transfer in Assisted Reproduction Programs31.702
Prevalence of abnormal semen analysis and levels of adherence with fertility preservation in men undergoing therapy for newly diagnosed cancer: A retrospective study in 2906 patients31.702
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol31.702
GnRH Agonist at Embryo Transfer: IVF Outcomes31.702
Clinical Cohort Study on the Endocrinology and Vaginal Microbiome of the Luteal Phase in Assisted Reproduction31.702
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression31.702
Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)31.702
Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?31.702
Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles31.702
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol31.702
Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference31.702
Neonatal outcomes following different ovarian stimulation protocols in fresh single embryo transfer31.702
What advice should we give our patients to preserve their fertility and avoid needing oocyte donation in the future? - A Social Fertility Preservation program31.702
Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment31.702
Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment31.702
Random-start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer31.702
Biomarkers of Ovarian Reserve and Correlation With IVF Treatments31.702
Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study31.702
A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment31.702
Bed Rest or no Bed Rest?31.702
The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)31.702
Egg Freezing Pilot Study31.702
MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer31.702
Temporally Splitting Ovarian Stimulation and Embryo Transfer31.702
Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility31.702
EmbryoGlue as an Embryo Transfer Medium31.702
The Accuracy of Endometrial Ultrasound to Predict Implantation31.702
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer31.702
Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility31.702
Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates31.702
Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial.31.702
Endometrial Scratch Injury in Women With Unexplained Infertility Undergoing IUI31.702
HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients31.702
Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment31.702
Fertility Preservation in Breast Cancer Patients31.702
To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment31.702
NATural Ovarian Stimulation31.702
Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles31.702
Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients31.702
HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients31.702
A randomized trial between GIFT and ovarian stimulation for the treatment of unexplained infertility and failed artificial insemination by donor31.702
The performance of primary and secondary unexplained infertility in an in vitro fertilization-embryo transfer program31.702
Outcome of in-vitro fertilization and embryo transfer after different regimens of ovarian stimulation31.702
Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer31.702
Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer31.702
In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings31.702
An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme31.702
The effect of periovarian adhesions on follicular development in patients undergoing ovarian stimulation for in vitro fertilization-embryo transfer31.702
Morphometric characteristics of endometrial biopsies after different types of ovarian stimulation for infertility treatment31.702
Gamete intra-Fallopian transfer or in-vitro fertilization after failed ovarian stimulation and intrauterine insemination in unexplained infertility?31.702
Sonographically monitored ovarian stimulation for assisted reproduction: a prospective, blind study31.702
In vitro fertilization/embryo transfer in unexplained infertility and minimal peritoneal endometriosis31.702
Fallopian Tube Sperm Perf usion Has No Advantage over Intra-uterine Insemination when Used in Combination with Ovarian Stimulation for the Treatment of Unexplained Infertility31.702
Methodology of human embryo transfer following assisted reproduction31.702
Immunity to zona pellucida in women with low response to ovarian stimulation, in unexplained infertility and after multiple IVF attempts31.702
Infertility evaluation in fertile women: a model for assessing the efficacy of infertility testing31.702
A prospective randomized crossover comparison of zygote intrafallopian transfer and in vitro fertilization-embryo transfer in unexplained infertility31.702
The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination31.702
Luteinizing hormone (LH) surge in patients using buserelin spray during ovarian stimulation for assisted reproduction31.702
Reproductive medicine and assisted reproduction--present status and perspectives in the Czech Republic31.702
Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment31.702
A comparison of early gestational age markers in viable twin pregnancies resulting from in vitro fertilization-embryo transfer versus spontaneous conception with ovarian stimulation31.702
A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid31.702
Relationship between semen cultures, leukospermia, and semen analysis in men undergoing fertility evaluation31.702
The influence of infertility treatment and assisted reproduction techniques on multiple pregnancy rates31.702
Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction31.702
Embryo transfer: a critical step in assisted reproduction31.702
A case of forearm amputation after ovarian stimulation for in vitro fertilization-embryo transfer31.702
Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation31.702
Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer31.702
Transfer of early-cleaved embryos increases implantation rate in patients undergoing ovarian stimulation and ICSI-embryo transfer31.702
The Impact of Lifestyle on Sperm Telomere Length and Telomerase Activity in Men Undergoing IVF Treatments31.702
Infertility treatment and informed consent: current practices of reproductive endocrinologists31.702
Intrauterine insemination IUI: the effect of ovarian stimulation and infertility diagnosis on pregnancy outcome31.702
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction31.702
Follitropin-alfa for ovarian stimulation during assisted reproduction treatment: a national collaborative study31.702
Effectiveness and treatment for unexplained infertility31.702
Blastocyst culture and transfer in clinical-assisted reproduction31.702
Access to fertility treatment by gays, lesbians, and unmarried persons31.702
Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines31.702
[Towards a single embryo transfer: predictive value of uterine and embryological parameters in assisted reproduction outcome]31.702
Cervical dilatation with hygroscopic rods prior to ovarian stimulation facilitates embryo transfer31.702
Elective single embryo transfer in assisted reproduction31.702
Health of children born after the infertility treatment with Assisted Reproduction Technology31.702
Removal of cervical mucus prior to embryo transfer improves pregnancy rates in women undergoing assisted reproduction31.702
Blastocyst production and transfer in clinical assisted reproduction31.702
Shared-risk or refund programs in assisted reproduction31.702
Embryo splitting for infertility treatment31.702
Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples31.702
Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)31.702
Fertility treatment when the prognosis is very poor or futile31.702
Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment?31.702
In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre31.702
Elective single embryo transfer versus double embryo transfer in assisted reproduction31.702
Single embryo transfer in IVF treatment31.702
Recombinant gonadotrophins in reproductive medicine: gold standard for ovarian stimulation therapy in the 21st century31.702
Guidelines for reducing the risk of viral transmission during fertility treatment31.702
Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results31.702
Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer31.702
Fertility treatment when the prognosis is very poor or futile: a committee opinion31.702
Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold?31.702
Results after assisted reproduction at a public fertility clinic31.702
Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial31.702
Strategies for hormonal ovarian stimulation in IVF, based on materials of the centre for assisted reproduction "varna"31.702
Effect of different embryo transfer strategies on the outcome of assisted reproduction31.702
Re: "Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births"31.702
Uterine contractile activity at Embryo Transfer – as a new pharmacotherapeutic target in assisted reproduction31.702
AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan31.702
Re: Semen Analysis in Adolescent Cancer Patients prior to Bone Marrow Transplantation: When is it Too Late for Fertility Preservation?31.702
Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH31.702
Nurses as a support to improve the quality of life during assisted reproduction31.702
Re: Fruit and Vegetable Intake and Their Pesticide Residues in Relation to Semen Quality among Men from a Fertility Clinic31.702
Processing of semen by density gradient centrifugation selects spermatozoa with longer telomeres for assisted reproduction techniques31.702
Re: Semen Analysis in Adolescent Cancer Patients Prior to Bone Marrow Transplantation: When is it Too Late for Fertility Preservation?31.702
Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers31.702
Successful pregnancy following assisted reproduction and transmyometrial embryo transfer in a patient with anatomical distortion of the cervical canal31.702
Is gonadotropin ovarian stimulation for unexplained infertility any longer warranted?31.702
Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility31.702
Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline31.702
Endometriosis does not affect live birth rates of patients submitted to assisted reproduction techniques: analysis of the Latin American Network Registry database from 1995 to 201131.702
ASRM standard embryo transfer protocol template: a committee opinion31.702
Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes31.702
Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion31.702
Timing of frozen-thawed embryo transfer after controlled ovarian stimulation in a non-elective freeze-all policy31.702
Current Preventive Strategies for Preovulatory Progesterone Elevation During Ovarian Stimulation for In Vitro Fertilization31.702
Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols31.702
Evidence-based treatments for couples with unexplained infertility: a guideline31.702
Predictors of twin pregnancy after ovarian stimulation and intrauterine insemination in women with unexplained infertility31.702
Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study31.702
Single and double embryo transfer provide similar live birth rates in frozen cycles31.702
Validation of a smartphone-based, computer-assisted sperm analysis system compared with laboratory-based manual microscopic semen analysis and computer-assisted semen analysis31.702
Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion31.702
Ovarian stimulation for fertility preservation in women diagnosed with cancer31.702
The impact of malignancy on response to ovarian stimulation for fertility preservation: a meta-analysis31.702
Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles31.702
Patient-centered care: factors associated with reporting a positive experience at United States fertility clinics31.702
Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic31.702
Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure31.702
Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates31.702
Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer31.702
Prospective randomized trial comparing efficacy of letrozole step-up protocol with letrozole plus gonadotropins for controlled ovarian stimulation and intrauterine insemination in patients with unexplained infertility31.702
Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment31.702
Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients31.702
Oocyte exposure to supraphysiological estradiol during ovarian stimulation increased the risk of adverse perinatal outcomes after frozen-thawed embryo transfer: a retrospective cohort study31.702
Effect of embryo transfer difficulty on live birth rates studied in vitrified-warmed euploid blastocyst transfers31.702
Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response31.702
Live birth rates and perinatal outcomes when all embryos are frozen compared with conventional fresh and frozen embryo transfer: a cohort study of 337,148 in vitro fertilisation cycles31.702
Live birth rates after different endometrial preparation methods in frozen cleavage-stage embryo transfer cycles: a randomized controlled trial31.702
Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial31.702
Vaginal cuff dehiscence following controlled ovarian stimulation recognized during egg retrieval31.702
Defining thresholds for abnormal premature progesterone levels during ovarian stimulation for assisted reproduction technologies31.702
Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology31.702
The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic31.702
[Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department]31.702
Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn's Disease and Ulcerative Colitis - A Nationwide Cohort Study31.702
Prediction of live birth and cumulative live birth rates in freeze-all-IVF treatment of a general population31.702
Risk factors for inadequate response to ovarian stimulation in assisted reproduction cycles: systematic review31.702
Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population31.702
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion31.702
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists31.702
Measuring serum estradiol and progesterone one day prior to frozen embryo transfer improves live birth rates31.702
Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study31.702
Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer31.702
Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply31.702
Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility31.702
[Cumulative live birth rates after frozen embryo transfer and fresh embryo transfer with oocyte numbers more than 15]31.702
Isthmocele and ovarian stimulation for IVF: considerations for a reproductive medicine specialist31.702
Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion31.702
Could fertility clinics offer a sizable improvement of live birth rates by maturing post-GVBD oocytes in vitro?31.702
Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations31.702
Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome31.702
Elective egg freezing and male support: a qualitative study of men's roles in women's fertility preservation31.702
Analysis of embryo quality with luteal phase ovarian stimulation after failed in vitro fertilization-embryo transfer with long or ultra-long protocol31.702
Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility31.702
Impact of Female Obesity on Cumulative Live Birth Rates in the First Complete Ovarian Stimulation Cycle31.702
Live Birth Rates in Poor Responders' Group after Previous Treatment with Autologous Platelet-Rich Plasma and Low Dose Ovarian Stimulation Compared with Poor Responders Used Only Low Dose Ovarian Stimulation Before in Vitro Fertilization31.702
Ovarian stimulation for fertility preservation or family building in a cohort of transgender men31.702
The Impact of Traditional Medicine-Based Lifestyle and Diet on Infertility Treatment in Women Undergoing Assisted Reproduction: A Randomized Controlled Trial31.702
Impact of Melatonin Supplementation in Women with Unexplained Infertility Undergoing Fertility Treatment31.702
Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis31.702
Transvaginal ovarian drilling followed by controlled ovarian stimulation from the next day improves ovarian response for the poor responders with polycystic ovary syndrome during IVF treatment: a pilot study31.702
Evaluation of the effect of the elective blastocyst-stage embryo transfer and freezing strategy on the abandonment of frozen embryos under the Taiwan National Assisted Reproduction Act31.702
Patient perceptions and understanding of treatment instructions for ovarian stimulation during infertility treatment31.702
Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population31.702
Cumulative Live Birth Rates According to Maternal Body Mass Index After First Ovarian Stimulation for in vitro Fertilization: A Single Center Analysis of 14,782 Patients31.702
Endometrial volume measured on the day of embryo transfer is not associated with live birth rates in IVF: a prospective study and review of the literature31.702
No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies31.702
[Elective single embryo transfer in assisted reproduction]31.702
When is the optimal timing of frozen embryo transfer after controlled ovarian stimulation?31.702
Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial31.702
Changes in the levels of selected metabolites in the culture medium as a possible tool for the embryo selection in assisted reproduction31.702
Value of sperm acrosin activity detection in selecting the method of assisted reproduction for patients with unexplained infertility31.702
Effect of triple line vs isoechogenic endometrial texture on pregnancy outcome following embryo transfer according to use of controlled ovarian stimulation (COH) or estrogen/progesterone replacement31.702
Low progesterone levels on the day before natural cycle frozen embryo transfer are negatively associated with live birth rates31.702
Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study31.702
How fixed versus variable gonadotropin dose during controlled ovarian stimulation could influence the management of infertility patients undergoing IVF treatment: a national Delphi consensus31.702
Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics31.702
Importance of early and precise ascertainment of mosaic Turner syndrome for fertility preservation and assisted reproduction counseling31.702
Anti-Müllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 431.702
Customized Frozen Embryo Transfer after Identification of the Receptivity Window with a Transcriptomic Approach Improves the Implantation and Live Birth Rates in Patients with Repeated Implantation Failure31.702
Use of a male antioxidant nutraceutical is associated with superior live birth rates during IVF treatment31.702
Reduced live birth rates in frozen versus fresh single cleavage stage embryo transfer cycles: A cross -sectional study31.702
IVM Survey Among Reproductive Medicine Specialists31.702
Effect of uterine dimensions on live birth rates after single embryo transfer in infertile women31.702
Corrigendum to ``Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial" [Reproductive BioMedicine Online, Volume 38, Issue 3, March 2019, Pages 387-396]31.702
Ng Soon Chye31.702
Cumulative live birth rates following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF: a population-based retrospective cohort study31.702
Further evidence that a supraphysiologic estradiol level during ovarian stimulation affects birthweight: findings of fresh and frozen embryo transfer with comparable estradiol levels on human chorionic gonadotropin trigger31.702
Short-term weight change and live birth among women with unexplained infertility and polycystic ovary syndrome undergoing ovulation induction31.702
Early Progesterone Change Associated With Pregnancy Outcome After Fresh Embryo Transfer in Assisted Reproduction Technology Cycles With Progesterone Level of >1.5 ng/ml on Human Chorionic Gonadotropin Trigger Day31.702
Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis31.702
Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible31.702
Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment?31.702
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion31.702
Access to infertility evaluation and treatment in two public fertility clinics and the reasons for withholding it: a prospective survey cohort study of healthcare professionals31.702
The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites31.702
Simulation training for embryo transfer: findings from the American Society for Reproductive Medicine Embryo Transfer Certificate Course31.702
Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo31.702
An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review31.702
Expectant Management Before In vitro Fertilization in Women Aged 39 or Above and Unexplained Infertility Does Not Decrease Live Birth Rates Compared to Immediate Treatment31.702
A Federated Blockchain Approach for Fertility Preservation and Assisted Reproduction in Smart Cities31.702
Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?31.702
Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy31.702
Efficacy and Safety of Fertility Treatments and Fertility Preservation31.702
Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer31.702
Your Fertility Journey31.702
P–087 Paternal age clinical effect on cumulative live birth rates (CLBR) per inseminated oocyte, embryo transfer and embryo transferred in autologous IVF-ICSI cycles of infertile males31.702
P–090 Cumulative live birth rates (CLBR) per embryo transfer, embryo transferred and inseminated oocyte are not affected by paternal age in infertile male donor egg cycles31.702
Pregnancy Rate (PR) With In-Vitro Fertilization (IVF) When the Egg Retrieval (ER) and the Embryo Transfer (ET) are Done by the Same Physician or by Different Physicians31.702
Is Tubal Embryo Transfer (TET/ZIFT) of any Value? Meta-Analysis and Comparison with SART Data 1991–199631.702
Endometriosis does not impact live birth rates in frozen embryo transfer (FET) of euploid blastocysts31.702
Does PGT with fresh embryo transfer affect perinatal outcomes?: An analysis of the 2014 and 2015 SART data31.702
Optimizing utilization of emotional support during infertility treatment31.702
Towards personalised reproductive medicine: screening for genetic variants and its influence in controlled ovarian stimulation31.702
Gonadotropin-specific follicular steroidogenesis in ovarian stimulation: evidence from the menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial31.702
Time lapse selected elective single embryo transfer in hyaluronon enriched transfer medium in pcos improves live birth rates compared to use of conventional embryo transfer media. a possible alternative to freeze-all cycles in PCOS31.702
Elective egg freezing and male support: a qualitative study of men’s hidden roles in women’s fertility preservation31.702
Risk of ectopic pregnancy after different ovarian stimulation protocols in fresh single embryo transfer: analysis of 71,831 cycles from the Japanese ART registry31.702
Does Acupuncture Have Any Benefit in the IVF Treatment of Couples with Unexplained Infertility; A Prospective Randomized Controlled Trial31.702
Selective Discontinuation of Luteal Phase Support in Assisted Reproduction Cycles Using a Gonadotropin-Releasing Hormone Agonist and Human Menopausal Gonadotropins for Ovarian Stimulation31.702
Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes31.702
Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology31.702
What are the benefits and harms of intrauterine administration of human chorionic gonadotropin (hCG) around the time of embryo transfer for subfertile women undergoing assisted reproduction?31.702
Recombinant FSH dosing during controlled ovarian stimulation in IVF treatment31.702
Impact of the Duration of Controlled Ovarian Stimulation on Assisted Reproduction Cycle Outcomes31.702
Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer31.702
What Medically Assisted Reproduction Should Be Offered in Unexplained Infertility?31.702
Singletons birthweight after frozen-thawed embryo transfer is increased after endometrial preparation with artificial cycle compared to mild gonadotropin ovarian stimulation31.702
Ovarian stimulation is a safe and effective fertility preservation (FP) option in the adolescent population31.702
Egg freezing for fertility preservation and family planning: a survey of OB/GYN residents across united states31.702
Random start versus conventional start controlled ovarian stimulation in women with cancer: comparing oocyte yield among fertility preservation cycles31.702
Anti-mullerian hormone level as a predictor of ovarian reserve in patients seeking fertility preservation versus infertility treatment31.702
Patient-centered care: factors associated with reporting a positive experience at U.S. fertility clinics31.702
impact of breast cancer prognostic factors on the response to controlled ovarian stimulation patients undergoing fertility preservation31.702
In freeze all embryos (FAE) cycles due to endometrial fluid (EF), live birth rates in subsequent frozen embryo transfer (FET) are comparable to those of controls, despite high rates of EF recurrence and cycle cancellation31.702
How does freeze-all strategy compare with conventional in vitro fertilization and fresh embryo transfer during assisted reproduction?31.702
Antral Follicle Count versus Basal Follicle Stimulating Hormone as Predictors of Ovarian Response in Women Undergoing Superovulation with Long Protocol for Assisted Reproduction31.702
Q13719122231.702
Cyprus Fertina IVF Clinic31.702
Journal of Contemporary History21.410
National Center for Biotechnology Information21.410
arXiv21.410
March of Dimes Prize in Developmental Biology21.410
Q18068621.410
Oregon Health and Science University21.410
Journal of Egyptian Archaeology21.410
eMedicine21.410
Clinical Breast Cancer21.410
Clinical Genitourinary Cancer21.410
Clinical Colorectal Cancer21.410
Clinical Lung Cancer21.410
Francis Collins21.410
American Congress of Obstetricians and Gynecologists21.410
HomoloGene21.410
United States Centers for Disease Control and Prevention21.410
Cystic Fibrosis Foundation21.410
Johns Hopkins School of Medicine21.410
Blood21.410
GenBank21.410
Journal of Virology21.410
Pennsylvania Hospital21.410
Entrez21.410
Johns Hopkins Hospital21.410
Journal of Histochemistry and Cytochemistry21.410
Journal of Marketing21.410
Journal of Marketing Research21.410
polymyalgia rheumatica21.410
Morbidity and Mortality Weekly Report21.410
Journal of Peace Research21.410
Journal of Cardiovascular Pharmacology and Therapeutics21.410
Journal of the American Society of Echocardiography21.410
Seminars in Cancer Biology21.410
Cancer Treatment Reviews21.410
Nanoscale Research Letters21.410
Lou Ruvo Center for Brain Health21.410
eLife21.410
PeerJ21.410
Biophysical Journal21.410
Journal of Molecular and Cellular Cardiology21.410
Journal of Cardiac Failure21.410
Current Problems in Cardiology21.410
Royal College of Obstetricians and Gynaecologists21.410
Journal of Cardiovascular Magnetic Resonance21.410
Mayo Clinic Hospital — Rochester21.410
American Heart Journal21.410
European Journal of Surgical Oncology21.410
Cancer Biology and Therapy21.410
Planned Parenthood21.410
Cancer Imaging21.410
Cardiology clinics21.410
International Journal of Distributed Sensor Networks21.410
Astrobiology21.410
Pediatric Allergy, Immunology, and Pulmonology21.410
Bioscience Reports21.410
Environment and Planning21.410
ACS Chemical Neuroscience21.410
Acta Histochemica et Cytochemica21.410
American Journal of Medicine21.410
Analytical Chemistry Insights21.410
Aging21.410
Quarterly Journal of Experimental Psychology21.410
Brigham and Women's Hospital21.410
GeneReviews21.410
Biomicrofluidics21.410
Journal for the History of Astronomy21.410
Journal of Experimental Medicine21.410
Lipid Insights21.410
Molecular and Cellular Biology21.410
National Center for Health Statistics21.410
WebMD21.410
World Affairs21.410
Eugene Koonin21.410
Theology Today21.410
Cell Calcium21.410
Otolaryngologic Clinics of North America21.410
AAOHN Journal21.410
AIDS Research and Human Retroviruses21.410
Acupuncture in Medicine21.410
Advisory Committee on Immunization Practices21.410
Johns Hopkins All Children's Hospital21.410
Alternative Law Journal21.410
American Family Physician21.410
American Journal of Alzheimer's Disease & Other Dementias21.410
The American Journal of Emergency Medicine21.410
American Journal of Evaluation21.410
American Journal of Kidney Diseases21.410
American Journal of Lifestyle Medicine21.410
American Journal of Obstetrics and Gynecology21.410
Annals of Family Medicine21.410
Annals of Pharmacotherapy21.410
Anne Schuchat21.410
Antioxidants & Redox Signaling21.410
Antiviral Therapy21.410
Armed Forces & Society21.410
Asia-Pacific Journal of Public Health21.410
BabyCenter21.410
Best Practice & Research: Clinical Rheumatology21.410
Bioinformatics and Biology Insights21.410
Biomarker Insights21.410
California Management Review21.410
Canadian Journal of Gastroenterology & Hepatology21.410
Canadian Respiratory Journal21.410
Cancer Informatics21.410
Cerebral Cortex21.410
City and Community21.410
Clin-Alert21.410
Clinical Gastroenterology and Hepatology21.410
Clinical Lymphoma, Myeloma & Leukemia21.410
Clinical Medicine Insights: Oncology21.410
Clinical Ovarian Cancer & Other Gynecologic Malignancies21.410
Clinical and Applied Thrombosis-Hemostasis21.410
Clothing & Textiles Research Journal21.410
Cn3D21.410
Communication Research21.410
Community College Review21.410
Conceive21.410
Concurrent Engineering21.410
Conflict Management and Peace Science21.410
Consensus CDS Project21.410
Conserved Domain Database21.410
Contemporary Sociology21.410
Convergence21.410
Cornell Hospitality Quarterly21.410
Council on Foundations21.410
Critical Social Policy21.410
Cultural Sociology21.410
CytoJournal21.410
DNA and Cell Biology21.410
Emerging Infectious Diseases21.410
Dementia21.410
Diabetes Care21.410
Educational Evaluation & Policy Analysis21.410
Educational Researcher21.410
Election Law Journal21.410
Emory Healthcare21.410
Emory University Hospital21.410
Emory University Hospital Midtown21.410
Entrepreneurship Theory and Practice21.410
Epi Map21.410
Epidemic Intelligence Service21.410
Ethnography21.410
Eukaryotic Cell21.410
European Journal of Medical Research21.410
European Journal of Personality21.410
European Psychiatry21.410
European Union Politics21.410
Evidence-based Complementary and Alternative Medicine21.410
Evolutionary Bioinformatics21.410
Feminist Criminology21.410
Fire Fighter Fatality Investigation and Prevention Program21.410
Foot and Ankle Specialist21.410
Games and Culture21.410
General Music Today21.410
Genetic codes21.410
Gifted Child Quarterly21.410
Global Health Action21.410
Health Hazard Evaluation21.410
Hospital of the University of Pennsylvania21.410
Howard County General Hospital21.410
IBIS21.410
ICAN: Infant, Child, & Adolescent Nutrition21.410
IFLA Journal21.410
Indian Journal of Nephrology21.410
Information Development21.410
International Communication Gazette21.410
International Journal of Clinical and Experimental Medicine21.410
International Journal of Clinical and Experimental Pathology21.410
International Journal of Damage Mechanics21.410
International Journal of Offender Therapy and Comparative Criminology21.410
International Journal of Surgery21.410
International Regional Science Review21.410
Intervention in School and Clinic21.410
Jeff Stein21.410
Journal of Accounting, Auditing & Finance21.410
Journal of Adolescent Research21.410
Journal of Aging and Health21.410
Journal of Alternative and Complementary Medicine21.410
Journal of Applied Gerontology21.410
Journal of Applied Social Science21.410
Journal of Asian and African Studies21.410
Journal of Bioactive and Compatible Polymers21.410
Journal of Bone and Joint Surgery21.410
Journal of Business Communication21.410
Journal of Career Development21.410
Journal of Cases in Educational Leadership21.410
Journal of Computational Biology21.410
Journal of Conflict Resolution21.410
Journal of Cutaneous and Aesthetic Surgery21.410
Journal of Disability Policy Studies21.410
Journal of Educational and Behavioral Statistics21.410
Journal of Empirical Research on Human Research Ethics21.410
Journal of Evidence-Based Complementary & Alternative Medicine21.410
Journal of Hospitality & Tourism Research21.410
Journal of Industrial Textiles21.410
Journal of Intensive Care Medicine21.410
Journal of Laboratory Automation21.410
Journal of Language and Social Psychology21.410
Journal of Medical Ethics21.410
Journal of Mixed Methods Research21.410
Journal of Music Teacher Education21.410
Journal of Palliative Medicine21.410
Journal of Parenteral and Enteral Nutrition21.410
Journal of Plastic Film and Sheeting21.410
Journal of Psychology & Theology21.410
Journal of Reinforced Plastics and Composites21.410
Journal of Renal Nutrition21.410
Journal of Sport & Social Issues21.410
Journal of Studies in International Education21.410
Journal of Teacher Education21.410
Journal of Thermoplastic Composite Materials21.410
Journal of Transcultural Nursing21.410
Journal of the American Academy of Child and Adolescent Psychiatry21.410
Journal of the American Medical Directors Association21.410
Journal of the American Psychoanalytic Association21.410
Journal of the Experimental Analysis of Behavior21.410
Journal of the International AIDS Society21.410
Journal of the Renin-Angiotensin-Aldosterone System21.410
Journalism & Mass Communication Quarterly21.410
Language Testing21.410
Mayo Clinic Proceedings21.410
The Linacre Quarterly21.410
Lupus21.410
Systems Biology in Reproductive Medicine20.001
Robert Edwards20.001
Gigi Fernández20.001
embryo transfer20.001
reproductive medicine20.001
Unexplained infertility20.001
azoospermia20.001
doctor–patient relationship20.001
egg donation20.001
semen analysis20.001
Creighton Model FertilityCare System20.001
Vitrification (ovocytes)20.001
Volunteer Emotional Support Helplines20.001
Volks20.001
AirCraft Casualty Emotional Support Services20.001
Bedside Manner20.001
Bedside manner20.001
Center for Reproductive Medicine20.001
covert incest20.001
emotional support animal20.001
Endocrinology of reproduction20.001
fertility preservation20.001
Fertility testing20.001
fertility tourism20.001
Human Fertilisation and Embryology (Deceased Fathers) Act 200320.001